In Depth 7 May 2025
Unlocking immunity: the power of TLR agonists
Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.
Clinical trial
- Latest Posts
In Depth 30 Apr 2025
The future of NSCLC treatment: what’s in store for the therapeutic space?
Here we delve into the different kinds of NSCLC therapies in the running to potentially address late-stage cancer that is often difficult to treat.
News and Trends 28 Apr 2025
U.S. budget cuts: what is the impact on therapeutic research?
We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs and lawsuits.
Best in Biotech 22 Apr 2025
Seven biotechs to watch in the hepatitis B space
Here we take a look at seven biotechs with clinical drug candidates on a quest to win regulatory approval to treat HBV.
In Depth 9 Apr 2025
Cystic fibrosis: is the next blockbuster a gene therapy?
Learn about the biotechs progressing their gene therapies for cystic fibrosis and why it might just be the breakthrough that patients need.
Best in Biotech 25 Mar 2025
These 7 biotechs are shaping the next generation of endometriosis care
As we observe Endometriosis Awareness Month in March, let us take a look at seven biotechs advancing promising candidates in the clinic.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 24 Mar 2025
First-ever RIPTAC enters clinic: all you need to know about this new cancer approach
The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.
News and Trends 21 Mar 2025
Depression drug trials are failing—and placebos are to blame
In this article, we examine recent clinical trial failures and discuss potential pathways forward for antidepressant drug research.
Interview 20 Mar 2025
AI meets biotech: Bullfrog AI’s CEO on the TechBio boom
Find out about how TechBios are changing the industry by leveraging AI and partnering with biotech in our interview with Bullfrog AI’s CEO.
Best in Biotech 18 Mar 2025
Cancer vaccines: 11 biotechs to keep an eye out for
As various biotechs across the world specialize in the production of cancer vaccines, here are 11 companies making progress in the field.
In Depth 17 Mar 2025
How biotechs are using AI to rescue failed drugs
Discover how biotech companies like Ignota Labs and BioXcel Therapeutics are using AI to rescue failed drugs.
In Depth 12 Mar 2025
Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next
Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.
ADVERTISEMENT
